Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Addict Behav. 2018 Oct 29;90:136–142. doi: 10.1016/j.addbeh.2018.10.042

Table 2.

Descriptive statistics by current PTSDa status, for participants who were eligible for the study (N = 50).

Never or prior PTSD (n=32) Current PTSD (n=18)
M or % SD M or % SD t(df) or χ2 p-value
Female 46.9% -- 50.0% -- 0.05 0.83
Age 43.98 11.60 44.49 13.15 −0.14 (48) 0.89
Hispanic 6.3% -- 5.6% -- 0.01 0.92
Minority 62.5% -- 33.3% -- 3.93 0.05
Veteran 75.0% -- 44.4% -- 4.67 0.03
Education (years) 13.94 2.72 13.78 2.90 0.19 (48) 0.85
FTNDb total score 4.44 2.12 5.83 1.69 −2.39 (48) 0.02
Age at smoking onset 15.67 5.47 14.53 3.86 0.76 (45) 0.45
Urine cotinine category at screeningc 5.13 0.91 5.22 0.81 −0.38 (48) 0.71
Cigarettes per day 13.47 6.03 18.59 7.68 −2.53 (45) 0.02
CAPSd total score (screening) 11.88 14.72 70.33 18.45 −12.3 (48) <.0001
Number of trauma categories endorsed 7.06 3.22 9.39 4.33 −2.16 (48) 0.04
CES-De total score (pre-quit) 9.30 7.62 27.59 11.75 −5.77 (27.8) <.0001
History of alcohol dependence/abuse 54.8% -- 58.8% -- 0.07 0.79
Motivation to quit (screening)f 9.15 1.17 9.28 0.83 −0.39 0.70
History of substance dependence/abuse 45.2% -- 58.8% -- 0.82 0.37
History of alcohol or substance dependence / abuse 74.2% -- 82.3% -- 0.41 0.52
a

posttraumatic stress disorder;

b

Fagerstrӧm Test for Nicotine Dependence;

c

0=0–10ng/ml, 1= 10–30ng/ml, 2=30–100ng/ml, 3=100–200ng/ml, 4=200–500ng/ml, 5=500–1000ng/ml, 6=>1000ng/ml;

d

Clinician Administered PTSD Scale;

e

Center for Epidemiologic Studies Depression Scale;

f

Contemplation Ladder (score range 0–10)